Insider filing · TBPH
Eran Broshy sold $1.1M of Theravance Biopharma (TBPH)
Executed Nov 11 2025, disclosed Nov 13 2025, 2 days later.
Value, as filed
$1.1M
59,000 sh across 3 lots
Executed
Nov 11 2025
the trade date, as filed
Disclosed
Nov 13 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
EB
Eran Broshy
Director
profile →
Eran Broshy (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales, 1 filed past the two-business-day deadline), most often in Theravance Biopharma, Inc. (TBPH). The largest single filing was $1.1M of TBPH (59,000 sh across 3 lots, as filed), executed Nov 11 2025.
The name
TBPH
Theravance Biopharma, Inc.
TBPH · Healthcare · 10 filings in 24 months
ticker →
Healthcare · Theravance Biopharma, Inc., a biopharmaceutical company, develops and commercializes medicines in the United States
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Eran Broshy in TBPH
TBPHSALE
Theravance Biopharma, Inc.
$590K29,501 sh across 2 lots
Exec Nov 26 2025
Filed Dec 1 2025 · 5:30 PM ET TBPHSALE Theravance Biopharma, Inc. $809K
45,000 sh across 3 lots
Exec Nov 11 2025
Filed Nov 14 2025 · 5:30 PM ET †